Results and discussion
Centrosome duplication is known to repeat during the prolonged early S phase induced by treatment of CHO cells with HU [4] . We first compared the effect of two cell cycle inhibitors, mimosine and HU, on centrosome duplication in CHO cells. Mimosine has been shown to inhibit the cell cycle in late G1 phase [7] . Cells were arrested in quiescent state (G0) and then induced to enter the cell cycle by the addition of serum. Quiescent cells contained one centrosome consisting of two centrioles ( Figure 1a , 0 h). In the presence of 2 mM HU, centrosome duplication is not blocked. About 50-60% of cells treated with HU for 40 hours had more than two centrioles per cell (which were clearly discernible), but about 30% of the cells had packed centrioles, the number of which could not be counted accurately. We therefore treated the cells with 0.5 µM okadaic acid (OA) for 40 minutes to separate these packed centrioles for accurate quantitation. After the OA treatment, about 88% of the cells contained more than two centrioles per cell (Figure 1b , HU 40 h). Using electron microscopy, we verified that centrosome duplication occurred without the OA treatment (see Supplementary material published with this paper on the internet).
The effect of mimosine on centrosome duplication was different from that of HU. In the presence of 0.4 mM mimosine, which inhibited S phase entry (data not shown), only two centrioles were detected in more than 90% of the cells even 40 hours after serum addition (Figure 1a,b) . Thus, no sign of centrosome duplication was observed in the presence of mimosine. We confirmed this by using electron microscopy (see Supplementary material). These results may suggest that centrosome duplication is dependent on some event occurring at the G1-S boundary.
Cdk2 is known to be activated as a Cdk2-cyclin E complex at the G1-S boundary and as a Cdk2-cyclin A complex during S phase progression [8] . We therefore examined Cdk2 activity in CHO cells treated with mimosine or HU. Lysates from cells treated with mimosine or HU were subjected to an immunocomplex kinase assay for Cdk2 with histone H1 as a substrate. In the presence of HU, Cdk2 activity increased significantly after the serum addition. In the presence of mimosine, however, the increase in Cdk2 activity was significantly inhibited (Figure 1c ). Both the cyclin-E-associated H1 kinase activity and the cyclin-Aassociated H1 kinase activity were much lower in the presence of mimosine than in the presence of HU (Figure 1c) . Thus, mimosine, but not HU, arrests the cell cycle before the rise in the activity of Cdk2, as suggested previously [9] . We therefore hypothesized that centrosome duplication must depend on the activity of Cdk2.
To test this hypothesis, we examined whether inhibition of Cdk2 activity suppresses the repeated centrosome duplication in the presence of HU. To inhibit Cdk2 activity, we used two drugs, butyrolactone I and roscovitine, both of which are reported to inhibit specifically the kinase activity of Cdk2, Cdc2 or Cdk5 [6] . In a control experiment in which dimethylsulfoxide (DMSO) was added (the solvent for the drugs), about 77% of the cells contained more than two centrioles per cell in the presence of HU. In contrast, 85.7% of butyrolactone-I-incubated cells and 86.6% of roscovitine-incubated cells still had only two centrioles per cell (Figure 2 ). Thus, both butyrolactone I and roscovitine strongly inhibited the continued centrosome duplication in the presence of HU.
Next, we expressed the Cdk inhibitor p21 Waf1/Cip1 (p21) in HU-treated CHO cells to inhibit the activity of Cdk2. We transfected a p21 expression plasmid or empty vector together with a green fluorescent protein (GFP) expression plasmid as a transfection marker. By immunostaining with anti-p21 antibody, we confirmed that p21 and GFP were co-expressed (data not shown). Most of the cells transfected with empty vector (about 89%), like non-transfected cells, contained more than two centrioles per cell. In contrast, the majority of the p21-expressing cells (about 68%) had only two centrioles per cell (Figure 3 ). Taken together, these results indicate that Cdk2 activity is required for centrosome duplication.
To test whether an increase in Cdk2 activity reverses the inhibitory effect of mimosine treatment on centrosome duplication, we overexpressed Cdk2 in mimosine-treated cells. We transfected wild-type Cdk2 or kinase-dead Cdk2 (a single amino acid substitution of Thr160 for alanine) [10] expression plasmids, or empty vector, together with GFP plasmid. By immunostaining with anti-Cdk2 antibody, we confirmed that Cdk2 and GFP were coexpressed (data not shown). The majority of the cells transfected with either the empty vector or the kinasedead Cdk2 (about 77%) had only two centrioles per cell in the presence of mimosine. In contrast, most of the cells expressing wild-type Cdk2 (about 71.7%) contained more than two centrioles per cell in the presence of mimosine (Figure 4a,b) . Using electron microscopy, we confirmed that centrosome duplication actually occurred in the cells expressing wild-type Cdk2. We identified GFP-expressing cells on CELLocates (Eppendorf) before fixation. In four cells examined that expressed wild-type Cdk2, three cells contained four centrioles per cell and one contained three centrioles; these cells had normal triplet microtubules (Figure 4c ). Only two centrioles per cell were seen in all the cells examined that had been transfected with either empty vector or the kinase-dead Cdk2 plasmid (Figure 4c ). The H1 kinase activities of the immunoprecipitates obtained with anti-Cdk2, anti-cyclin E or anticyclin A antibodies were significantly higher in the cells expressing wild-type Cdk2 than in the cells transfected with empty vector or the kinase-dead Cdk2 plasmid (see Supplementary material). Thus, the increased H1 kinase activity of Cdk2 seems to be associated with both cyclin E and cyclin A. All these results clearly indicate that an increase in Cdk2 activity is able to reverse the inhibition of centrosome duplication induced by mimosine treatment and therefore support our idea that Cdk2 activity is required for centrosome duplication.
Our results strongly suggest that centrosome duplication is under the control of Cdk2. This enzyme has been previously shown to control DNA replication [8] . Therefore, we propose that activation of Cdk2 is the mechanism that ensures the concurrence of centrosome duplication and DNA replication. The continued centrosome duplication in the absence of DNA replication [1, 4, 5] is likely to be due to the relatively high Cdk2 activity in the prolonged S phase that occurs under these conditions. In the absence of protein synthesis, cells cannot enter mitosis because of the lack of mitotic cyclins, but centrosome duplication continues in the early embryos of the frog [3] and sea urchin [2] though does not continue in somatic cells [11] . Oscillations in the activity of Cdk2 are independent of protein Brief Communication 431 synthesis during the early embryonic cell cycles in Xenopus [12] . In contrast, the formation of active Cdk2-cyclin E complex in somatic cells requires de novo synthesis of cyclin E [13] . Moreover, abnormal centrosome duplication is a possible cause of the genomic instability frequently seen in cancer cells [14, 15] . Centrosome duplication is possibly restricted to one cycle by the proper control of Cdk2 activity.
In conclusion, we have demonstrated the dependence of centrosome duplication on the Cdk2 cell cycle engine in mammalian cells. Therefore, our findings suggest an underlying mechanism for the coordination of centrosome duplication with the cell cycle. After submission of this work, a paper appeared that reports a similar observation in Xenopus egg extracts [16] .
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